bisindolylmaleimide i has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cenac, N; Hollenberg, MD; Houle, S; Hyun, E; Liblau, RS; Ramachandran, R; Rousset, P; Saxena, A; Vergnolle, N | 1 |
1 other study(ies) available for bisindolylmaleimide i and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide
Article | Year |
---|---|
Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response.
Topics: Animals; Calcium; Cell Line; Cells, Cultured; Chromones; Diabetes Mellitus, Type 1; Endothelial Cells; Female; Ganglia, Spinal; Humans; Hypoglycemic Agents; Immunity, Innate; Indoles; Inflammation; Insulin; Leukocyte Rolling; Male; Maleimides; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Morpholines; Neurons; Oligopeptides; Receptor, PAR-2; Signal Transduction | 2010 |